Cuban PM Manuel Marrero Cruz highlighted the solidarity of 11 members of the Henry Reeve Brigade who arrived in Havana on Wednesday after supporting the Republic of Togo in the fight against the current health crisis caused by COVID-19.
The Cuban Biotechnology and Pharmaceutical Industries Group (BioCubaFarma) and the English Company SG Innovations Ltd. formed the BioFarma Innovations joint venture, “focused on accelerating the development and accessibility in Europe and the British Commonwealth of innovative and leading medicines to world level”.
The first phase of clinical evaluation of the CIGB-300, a new drug with antiviral action to deal with COVID-19, recently concluded with encouraging results.
The videoconference "Cuban medicine in the fight against COVID-19" took place with the participation of around 30 Russian entities and important Cuban research centers.
Cuba has the capacity to develop telemedicine and receive income from it, especially now that its healthcare system's prestige has grown by helping to confront COVID-19 in dozens of nations, Olga Stolik Lipszyc, research professor at the International Economic Research Center (CIEI by its Spanish acronym), said in Havana.